Skip to content

Treace Medical Concepts, Inc.

TMCI· NasdaqCore metricsCIK 1630627

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · +6.15%
Market cap
$350.74M
65.56M shares
Filings
447
$48.25M
Q3 2026+1.6% FY25 yoy
-$12.57M
Q3 2026N/M FY25 yoy
-$11.53M
Q3 2026N/M FY25 yoy
-$8.15M
Q3 2026derivedN/M FY25 yoy
-$0.19
Q3 2026N/M FY25 yoy
$7.76M
Q3 2026−5.7% FY25 yoy
$350.74M
—
1.7×
5.7×
-5.29%
—

Twelve months to Sep 30, 2026 · derived

Price

$5.35+59.23%+$1.99past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$212.69MFY 2025
$212.69M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$212,690,000reported
FY 20242024-12-31$209,357,000reported
FY 20232023-12-31$187,118,000reported
FY 20222022-12-31$141,838,000reported
FY 20212021-12-31$94,419,000reported
FY 20202020-12-31$57,365,000reported
FY 20192019-12-31$39,416,000reported

Surgical & medical instruments & apparatus

Treace Medical Concepts, Inc. is the 41st largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Treace Medical Concepts, Inc. · CIK 1630627 · Engraved from SEC EDGAR